Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Keynote and Plenary Sessions
Concurrent Sessions
Event

Playback speed

10 seconds

Bispecific CAR19-22 and Sequential CAR22 Rescue: The Experience of a Few Prodigies

By Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium FEATURING David Miklos

11 views

September 9, 2021

Comments 0

The First Treatment Choice Matters

Feat. A. Ip

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Keynote and Plenary Sessions

Penn Medicine Q&A Panel on Cell Therapy During the COVID-19 Pandemic

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. Porter, C. Bollard, G. Shah, S. Maude, S. Devine

11 views

Penn Medicine Highlights on the Future of Cell and Gene Therapies fo…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

C. June

123 views

Penn Medicine Panel Discussion on Overcoming Resistance to Monothera…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

S. Maude, N. Frey, M. Pule, D. Miklos

15 views

Pediatric CAR T-Cell Therapy During COVID-19: CHOP Experience

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

S. Maude

18 views

Penn Medicine Updates on Creating Smarter T Cells for Immunotherapy

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

S. Riddell

88 views

AUTO3 and Beyond: Experience With Co-targeting of CD19 and CD22 in D…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

M. Pule

22 views

Bispecific CAR19-22 and Sequential CAR22 Rescue: The Experience of a…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. Miklos

11 views

Developing CAR T-Cell Therapies in Brazil

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

R. Cunha

Impact of COVID-19 on Recipients of HCT and CAR T-Cells

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

G. Shah

Decade-Long Remissions of Leukemia Sustained by the Persistence of A…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

J. Joseph Melenhorst

Penn Medicine Q&A Discussion on CAR T-Cell Therapy in Hematologic Ma…

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

R. Maziarz, T. Fry, A. Garfall, D. Maloney

19 views

Penn Medicine Updates on CAR T-Cell Therapy for Lymphoma

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

D. Maloney

30 views

Penn Medicine Updates on CAR T-Cell Therapy for Multiple Myeloma

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

A. Garfall

55 views

The Future of CAR T-Cell Therapy for ALL

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

T. Fry

16 views

CART22-65s Co-administered With huCART19 in Adult Patients With R/R …

Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

N. Frey

14 views